Evidence map›Paper›PMID 39796589›Full record

ArticleNutrients2024

Comparisons of Post-Load Glucose at Different Time Points for Identifying High Risks of MASLD Progression.

Long Teng, Ling Luo, Yanhong Sun, Wei Wang, Zhi Dong, Xiaopei Cao, Junzhao Ye, Bihui Zhong

Abstract readComparative Study
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Glucose curve morphology and peak time as biomarkers of metabolic health.American journal of physiology. Endocrinology and metabolism · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. cGAS-STING signaling in pollution-induced toxicity: mechanism and relieving medication.Apoptosis : an international journal on programmed cell death · 2026
    Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Long TengDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.
Ling LuoDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.
Yanhong SunDepartment of Clinical Laboratory, The First Affiliated Hospital, Sun Yat-sen University, No. 183 Huangpu East Road, Huangpu District, Guangzhou 510080, China.
Wei WangDepartment of Ultrasound, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.ORCID 0000-0002-9485-583X
Zhi DongDepartment of Radiology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.
Xiaopei CaoDepartment of Endocrinology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.ORCID 0000-0002-4402-7032
Junzhao YeDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.
Bihui ZhongDepartment of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, No. 58 Zhongshan II Road, Yuexiu District, Guangzhou 510080, China.ORCID 0000-0002-4638-7699

Funding

National Natural Science Foundation of China 82100648National Natural Science Foundation of China 82370587Natural Science Foundation of Guangdong Province 2022A1515012369
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood GlucoseFatty LiverAdultAgedBiomarkersDisease ProgressionFemaleGlucose Tolerance TestHumansLiver CirrhosisMaleMiddle AgedPrediabetic StateRetrospective StudiesRisk FactorsTime FactorsBiomarkersBlood Glucosealanine aminotransferaseatherosclerotic cardiovascular diseaseclinical outcomesliver fibrosisliver steatosismetabolic dysfunction-associated steatotic liver diseaseoral glucose tolerance testpost-load glucose

Identifiers

PMID39796589
PMCPMC11723153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.